Creative Diagnostics Launches HPV L1 Antibodies for Neutralization and Vaccine Development
Summary
Shirley, NY, February 17, 2023 --( PR.com )-- Creative Diagnostics, a global leader in providing raw materials, antibodies, and reagents for the biotechnology industry, recently introduced a series of HPV vaccine development products. However, later clinical trials have proven that IgG plays a major role in anti-HPV infection. Moreover, certain types of E6 and E7 can downregulate type I IFN interferon expression by interfering with the cell cycle as well.The immune response caused by natural infection is weak, and it is difficult to produce antibodies with sufficient titers to neutralize the invading viruses. The inoculation of preventive vaccines will stimulate the body to produce high titers of neutralizing antibodies to remove invading viruses. Clinical results show that neutralizing antibodies produced by HPV vaccines can penetrate the blood vessel walls to reach the site of infection, bind to the viruses, and make them lose their ability to infect cells.